Arkolith/Insider Trading/DNA/Form 4

Coen Steven P.

See remarksGinkgo Bioworks Holdings, Inc. (DNA) · full profile →Form 4 · filed Jan 22, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$9K
Net Open-Market Flow
-$9K
Transactions
7
4 non-derivative · 3 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 20, 2026Sell(S)972$8.92$9K8K
Jan 16, 2026Option exercise(M)587——8K
Jan 16, 2026Option exercise(M)156——8K
Jan 16, 2026Option exercise(M)1K——9K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jan 16, 2026Option exercise(M)587——9K
Jan 16, 2026Option exercise(M)156——4K
Jan 16, 2026Option exercise(M)1K——0

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001628280-26-003084) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML